Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest Expenses (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Interest Expenses for 5 consecutive years, with $302000.0 as the latest value for Q2 2025.

  • For Q2 2025, Interest Expenses fell 24.69% year-over-year to $302000.0; the TTM value through Dec 2025 reached $649000.0, down 59.26%, while the annual FY2024 figure was $1.6 million, 2.77% up from the prior year.
  • Interest Expenses hit $302000.0 in Q2 2025 for Kezar Life Sciences, down from $347000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $403000.0 in Q3 2024 and bottomed at $159000.0 in Q4 2021.
  • Average Interest Expenses over 5 years is $342400.0, with a median of $370000.0 recorded in 2023.
  • Year-over-year, Interest Expenses surged 119.5% in 2022 and then decreased 24.69% in 2025.
  • Kezar Life Sciences' Interest Expenses stood at $159000.0 in 2021, then surged by 119.5% to $349000.0 in 2022, then increased by 14.33% to $399000.0 in 2023, then decreased by 2.51% to $389000.0 in 2024, then dropped by 22.37% to $302000.0 in 2025.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $302000.0, $347000.0, and $389000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.